Ventricular Assist Devices

NIH awards contract to develop implantable blood pump for babies

Published in Medical Letter on the CDC and FDA, May 30th, 2004

MedQuest Products, Inc., was notified by the National Heart, Lung and Blood Institute that its R&D consortium was awarded a 5-year, $4.5 million contract to develop an implantable, left ventricular assist device (VAD) to support the failing heart of newborns for periods up to 6 months.

This was one of five such awards made nationwide. MedQuest's consortium is led by its academic R&D partner, the University of Pittsburgh (Pennsylvania), under the leadership of Dr. Harvey Borovetz, chairman of bioengineering.

According to Borovetz, "The Pediatric VAD [PVAD] is designed to support newborns who are born with congenital heart defects and undergo...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2004-05-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry